The plasma Hp level, Hp expression in tumor cells, and Hp fucosylation are reportedly related to cancer development and have been suggested to be candidate biomarkers of various cancers including HCC, colorectal cancer, pancreatic cancer, and glioblastoma [20, 33, 34]. The gene discussed is HP; the disease is colorectal cancer.